TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: importance to cut down
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: readiness to stop
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: importance and likelihood to cut down
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Left Ventricular (LV) function measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Right Ventricular (RV) function measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Extent of leakage at enamel and dentin margins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SF-36 physical and general health perceptions
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: disease-specific measures
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acute grade ≥2 GI toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Acute grade ≥2 urinary toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: time to eligibility of discharge from the cardiac recovery unit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative persistence of air leaks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time to complete walking and stair-climbing test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of concussions in tacklers
Endpoint domain: Adverse events/effects
Primary endpoint: Concussions per 1000 tackles
Endpoint domain: Adverse events/effects
Primary endpoint: Anterior chamber depth measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraocular lens power needed for emmetropia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhibition of Rac1 signaling pathway
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: clinically significant perceived benefit
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Identification of potentially repairable wounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Identification of patients requiring tetanus prophylaxis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: non-severe nocturnal hypoglycaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: ProBNP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Six-minute walking test distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Grade III oral mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Grade III dysphagia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital admission for treatment toxicity
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: RV global longitudinal strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: vascular access-site complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Ephedrine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse maternal effects
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of severe hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total knee replacement
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in Unified PD Rating Scale motor scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change from baseline in morning pre‐dose trough FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Cormack & Lehane scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fear of Progression (FoP)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Tolerability of knee lavage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: xerostomia scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient-reported current pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regression of rubeosis iridis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: readiness to retrofit tractors
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: intentions to retrofit tractors
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: message recall
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Smoking status identification rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Counseling rate for smoking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in p53 and BclII expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in computed tomography‐detected lung nodules
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum HSP‐70 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of life-MCS
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Skin conductance change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: measures of diabetes control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in health status in the past 12 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bodily pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of intraocular sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of third-trimester severe anaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: risk of third-trimester maternal parasitaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: risk of low birthweight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean CV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean DLP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete recovery from oculomotor nerve palsy (ONP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: compassion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: depression reduction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: injury risks related to burn safety practices
Endpoint domain: Adverse events/effects
Primary endpoint: shorter overall survival
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of BPD at 36 weeks postconceptional age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Passive rotational stiffness of the forearm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PTSD improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intentional self-injury
Endpoint domain: Adverse events/effects
Primary endpoint: activities of daily living (UPDRS II)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Completed vaginal delivery within 12 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Apgar scores of less than 7 at 1 minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: ALT values >3 times the upper limit of the reference range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: visual acuity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relapse within 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: wake-after-sleep onset
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TIMI major bleeding at 30 days
Endpoint domain: Adverse events/effects
Primary endpoint: anxiety increase
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: intake of the target vegetable
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: liking of the target vegetable
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Control of CINV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Steady state MAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to reach steady state MAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of operative ischemia
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: levels of subjective anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: definitive cure
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of intraoperative complications (OCR)
Endpoint domain: Adverse events/effects
Primary endpoint: Correct compression rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of ulcer recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression-free survival rate at 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Rectal temperature (T(re))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to temperature (TT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normalized protein catabolic rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum albumin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Coagulation levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Patient and investigator rated appearance improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Average worst pain during treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Midazolam clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of phlebitis
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of tenderness or discomfort
Endpoint domain: Adverse events/effects
Primary endpoint: recanalization rate
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in objective and subjective scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anxiety at discharge
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Diagnosis of ureteric obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement between imaging techniques
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of perirenal fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: soluble MAdCAM levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: circulating β7+ CD4+ central memory T-lymphocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Prevalence of WCH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ease of HBP monitoring
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plasma MDA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Acute renal injury (assessed by albuminuria, proteinuria, or enzymuria)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Circulating lymphocyte counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Disease control rate
Endpoint domain: Mortality/survival
Primary endpoint: Serum VLDL cholesterol level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of fluorescein angiographic CME
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual acuity recovery from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in hallucination scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma lipoprotein triacylglycerol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: plasma cholesterol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: plasma fatty acid concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Tsui score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of effect (time to retreatment)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parent-newborn attachment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Marital intimacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Postoperative number of medications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Avascular blebs
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of ipsilateral stroke
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of neurological complications (transient ischemic attacks and stroke combined)
Endpoint domain: Adverse events/effects
Primary endpoint: Freedom from recurrent stenosis at 24 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Complete ST segment resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Myocardial blood flow (MBF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Patient knowledge about OAT
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: unpleasantness of dyspnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: intensity of dyspnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Radiographically detected bone loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Implant success rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of temperatures in target range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjects reaching target temperature during transport
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach target temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSFS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OMERACT-OARSI responder criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum total and LDL-cholesterol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Waist-to-hip ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: POMA score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative IAA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: total 30-day LOS
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Seizure-free for ≥6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Sputum production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Intensity of depressive dimension of the blues symptomatology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective improvement in ocular comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: AOD measured at treadmill gradients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QLQ-C30 GHS/QoL scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: true time to deterioration for the QLQ-LC13 composite endpoint
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Serum cCa reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Surgical time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to achieving the DOI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of sensory block achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fat-free mass loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Upper and lower extremity strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: lymph node dissection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Average electromyography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: changed bodyweight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression of disease or death
Endpoint domain: Mortality/survival
Primary endpoint: Changes in CD4 cell counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in HIV RNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Uptake rate of the prenatal screening test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased R and K times
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Increased alpha angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Increased clot rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Control of International Normalised Ratio (INR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: improved health outcomes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: improved psychosocial outcomes
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: HA accumulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: no-reflow/slow flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CDP performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in postprandial glycemic and triglyceridemic control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Requirement of rescue analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in neurological deficits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improvement in subjective symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decreased risk of stroke recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Hospital for Special Surgery knee score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in sense of smell
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Study patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of graft thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: absolute CRF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relative CRF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: poor CRF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: earlier muscle activation timing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: earlier peak resultant GRF timing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improved kick quickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum HSP70 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase in daily water intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: meeting fluid targets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global motor performances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes